CLOSE X

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1433.1017.8 (+1.26 %)
PREV CLOSE ( ) 1415.30
OPEN PRICE ( ) 1426.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 650484
TODAY'S LOW / HIGH ( )1420.00 1461.25
52 WK LOW / HIGH ( )1165.55 1672.2
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Achin Gupta - Managing Director
Registered Office

Address Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 41916000

Email contactus@cipla.com / cosecretary@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
NEWS
16Jun Grant Of Stock Options And The Employ
Grant of Stock Options and Employee Stock Appreciation Rights (ESARs)
13May Cipla’s consolidated net profit falls
Cipla has reported results for the fourth quarter (Q4FY26) and year ende..
13May Cipla informs about investor presentat
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
13May Grant Of Stock Options And The Employ
Grant of stock options and employee stock appreciation rights (ESARs)
23Apr Cipla’s arm gets USFDA’s final nod for
Cipla’s wholly owned subsidiary -- Cipla USA Inc (Cipla) has received fi..
Financials
Rs. in Millions
QTR Mar 26 ANNUAL 26
Net Profit3846.435151.8
Gross Profit 5224.8 46359.4
Operating Profit 7783.355890.4
Net Sales 42099.8189799.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 18082.15 (5.12%)
M.Cap ( in Cr)23199.20
Gland Pharma (BSE)
 2298.60 (5.19%)
M.Cap ( in Cr)37917.63
Venus Remedies (BSE)
 1765.55 (4.10%)
M.Cap ( in Cr)2360.01
CORONA Remedies (BSE)
 1914.05 (3.59%)
M.Cap ( in Cr)11706.35
Sanofi India (BSE)
 3411.05 (1.85%)
M.Cap ( in Cr)7855.86
Shareholding Pattern
PROMOTERS 29.21%
MUTUAL FUNDS/UTI 18.66%
NON-INSTITUTION 16.26%
FI/BANKS/INSURANCE 11.29%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data May 2026 Broking Complaints Data May 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.